BEYOND PATHOGENICITY: BIOACTIVE COMPOUNDS AND ANTIMICROBIAL POTENTIAL of Staphylococcus epidermidis’ Arnab CHATTERJEE, Kausik MONDAL, Sutapa SANYAL

Details: Hits: 185

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
License CC-BY.

cover biotech acta general

Biotechnologia Acta Т. 19, No. 3, 2026
P. 5- 23 , Bibliography 1331 , Engl.
UDC: 579.862:615.28
doi: https://doi.org/10.15407/biotech19.03.005

Full text: (PDF, in English)

BEYOND PATHOGENICITY: BIOACTIVE COMPOUNDS AND ANTIMICROBIAL POTENTIAL of Staphylococcus epidermidis

Arnab CHATTERJEE ¹, Kausik MONDAL ², Sutapa SANYAL ³

^1,2 University of Kalyani, Department of Zoology, Kalyani, Nadia, West Bengal, India
³ Bidhannagar College, Department of Zoology, Bidhannagar, Kolkata West Bengal, India

Aims. To review the antimicrobial potential of Staphylococcus epidermidis, particularly its bacteriocins and antimicrobial peptides (AMPs), and to highlight their possible applications in human health, food preservation, aquaculture, and other industrial sectors.

Methods. A literature-based review approach was adopted to analyze existing studies on S. epidermidis–derived antimicrobial compounds. Published research focusing on bacteriocins, AMPs, pathogen inhibition, strain safety, and potential applications across healthcare and non-healthcare sectors was examined.

Results. Studies indicate that S. epidermidis produces potent antimicrobial compounds, including bacteriocins and AMPs, which exhibit strong pathogen-specific activity. These compounds demonstrate inhibitory effects against several pathogens, notably methicillin-resistant Staphylococcus aureus (MRSA), and show promise in managing skin infections, chronic wounds, and biofilm-associated infections. Although the bacterium is widely present in natural environments, its potential applications in food preservation and aquaculture remain underexplored. Furthermore, the dual nature of S. epidermidis as both a beneficial commensal and an opportunistic pathogen has limited its broader utilization. However, recent advances in strain selection and genetic studies have identified non-virulent strains, such as S. epidermidis YTPW-4, which lack major pathogenic traits and may be suitable for safe biotechnological applications.

Conclusions. S. epidermidis–derived bacteriocins and AMPs represent promising antimicrobial agents with potential applications beyond healthcare, including sustainable food systems, aquaculture, and precision medicine. However, comprehensive safety assessments and further research are necessary to harness their therapeutic and industrial potential fully.

Keywords: Staphylococcus aureus, antimicrobial peptides (AMPs), antibiotics, bacteriocins, neoplasia, acne.

Arnab CHATTERJEE (ORCID ID: https://orcid.org/0009-0005-5222-9979
Kausik MONDAL (ORCID ID: https://orcid.org/0000-0003-2677-5966
Sutapa SANYAL(ORCID ID: https://orcid.org/0000-0003-3183-0907

References

REFERENCES

Weist, K., Diaz Högberg, L. (2014). ECDC publishes 2013 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe. Eurosurveillance, 19(46). https://doi.org/10.2807/1560-7917.ES2014.19.46.20962
Rolain, J. M., Abat, C., Jimeno, M. T., Fournier, P. E., Raoult, D. (2016). Do we need new antibiotics? Clinical Microbiology and Infection, 22(5), 408–415. https://doi.org/10.1016/j.cmi.2016.03.012
Fair, R. J., Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry, 6, 25–64. https://doi.org/10.4137/PMC.S14459
Berry, E. A., & Hillerton, J. E. (2002). The effect of selective dry cow treatment on new intramammary infections. Journal of Dairy Science, 85(1), 112–121. https://doi.org/10.3168/jds.S0022-0302(02)74059-9
Dingwell, R. T., Duffield, T. F., Leslie, K. E., Keefe, G. P., DesCoteaux, L., Kelton, D. F., Lissemore, K. D. (2002). The efficacy of intramammary tilmicosin at drying-off and other risk factors for the prevention of new intramammary infections during the dry period. Journal of Dairy Science, 85(12), 3250–3259. https://doi.org/10.3168/jds.S0022-0302(02)74413-5
Gruet, P., Maincent, P., Berthelot, X., Kaltsatos, V. (2001). Bovine mastitis and intramammary drug delivery: Review and perspectives. Advanced Drug Delivery Reviews, 50(3), 245–259. https://doi.org/10.1016/S0169-409X(01)00160-0
Varella Coelho, M. L., dos Santos Nascimento, J., Fagundes, P. C., Madureira, D. J., de Oliveira, ..., Bastos, M. C. F. (2007). Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis. Research in Microbiology, 158(7), 625–630. https://doi.org/10.1016/j.resmic.2007.07.002
García, P., Rodríguez, L., Rodríguez, A., Martínez, B. (2010). Food biopreservation: Promising strategies using bacteriocins, bacteriophages and endolysins. Trends in Food Science & Technology, 21(8), 373–382. https://doi.org/10.1016/j.tifs.2010.04.010
Balciunas, E. M., Castillo Martinez, F. A., Todorov, S. D., Franco, B. D. G. M., Converti, A., Oliveira, R. P. S. (2013). Novel biotechnological applications of bacteriocins: A review. Food Control, 32(1), 134–142. https://doi.org/10.1016/j.foodcont.2012.11.025
Duarte, A. F. S., Ceotto, H., Coelho, M. L. V., Brito, M. A. V., Bastos, M. C. F. (2013). Identification of new staphylococcins with potential application as food biopreservatives. Food Control, 32(1), 313–321. https://doi.org/10.1016/j.foodcont.2012.12.008
Cotter, P. D., Hill, C., Ross, R. P. (2005). Bacteriocins: Developing innate immunity for food. Nature Reviews Microbiology, 3(10), 777–788. https://doi.org/10.1038/nrmicro1273
Piñón, D., Casas, M., Blanch, M., Fontaniella, B., Blanco, Y., Vicente, C., Gillis, M. (2002). Gluconacetobacter diazotrophicus, a sugar cane endosymbiont, produces a bacteriocin against Xanthomonas albilineans, a sugar cane pathogen. Research in Microbiology, 153(6), 345–351. https://doi.org/10.1016/S0923-2508(02)01336-0
Meaney, B., Ryan, M. P., Flynn, J., Hill, C., Ross, R. P. (1999). The use of a non-antibiotic teat sealer in combination with a food-grade bacteriocin, lacticin 3147, for mastitis prevention in non-lactating dairy cows. Cattle Practice, 7, 215–219.
Sahl, H. G., Bierbaum, G. (1998). Lantibiotics: Biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria. Annual Review of Microbiology, 52(1), 41–79. https://doi.org/10.1146/annurev.micro.52.1.41
Klaenhammer, T. R. (1988). Bacteriocins of lactic acid bacteria. Biochimie, 70(3), 337–349. https://doi.org/10.1016/0300-9084(88)90206-4
Coton, E., Mulder, N., Coton, M., Pochet, S., Trip, H., Lolkema, J. S. (2010). Origin of the putrescine-producing ability of the coagulase-negative bacterium Staphylococcus epidermidis Applied and Environmental Microbiology, 76(16), 5570–5576. https://doi.org/10.1128/aem.00441-10
Götz, F., Bannerman, T., Schleifer, K. H. (2006). The genera Staphylococcus and Macrococcus. In The Prokaryotes (pp. 5–75). https://doi.org/10.1007/0-387-30744-3_1
Irlinger, F. (2008). Safety assessment of dairy microorganisms: Coagulase-negative Staphylococci. International Journal of Food Microbiology, 126(3), 302–310. https://doi.org/10.1016/j.ijfoodmicro.2007.08.016
Schleifer, K. H., Kloos, W. E. (1975). Isolation and characterization of staphylococci from human skin I. Amended descriptions of Staphylococcus epidermidis and Staphylococcus saprophyticus and descriptions of three new species: Staphylococcus cohnii, Staphylococcus haemolyticus and Staphylococcus xylosus. International Journal of Systematic Bacteriology, 25(1), 50–61. https://doi.org/10.1099/00207713-25-1-50
Fey, P. D., Olson, M. E. (2010). Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiology, 5(6), 917–933. https://doi.org/10.2217/fmb.10.56
Paul, S. I., Rahman, M. M., Salam, M. A., Khan, M. A. R., Islam, M. T. (2021). Identification of marine sponge-associated bacteria of the Saint Martin’s Island of the Bay of Bengal emphasizing on the prevention of motile Aeromonas septicemia in Labeo rohita. Aquaculture, 545, 737156. https://doi.org/10.1016/j.aquaculture.2021.737156
Augustin, J., Rosenstein, R., Wieland, B., Schneider, U., Schnell, N., Engelke, G., et al. (1992). Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. European Journal of Biochemistry, 204(3), 1149–1154. https://doi.org/10.1111/j.1432-1033.1992.tb16740.x
Heidrich, C., Pag, U., Josten, M., Metzger, J., Jack, R. W., Bierbaum, G., ..., Sahl, H. G. (1998). Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Applied and Environmental Microbiology, 64(9), 3140–3146. https://doi.org/10.1128/aem.64.9.3140-3146.1998
Kaletta, C., Entian, K. D., Kellner, R., Jung, G., Reis, M., Sahl, H. G. (1989). Pep5, a new lantibiotic: Structural gene isolation and prepeptide sequence. Archives of Microbiology, 152(1), 16–19. https://doi.org/10.1007/bf00447005
Van De Kamp, M., Horstink, L. M., Van Den Hooven, H. W., Konings, R. N. H., Hilbers, C. W., Frey, A., ..., van de Ven, F. J. (1995). Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis European Journal of Biochemistry, 227(3), 757–771. https://doi.org/10.1111/j.1432-1033.1995.0757p.x
McAuliffe, O., Ross, R. P., Hill, C. (2001). Lantibiotics: Structure, biosynthesis and mode of action. FEMS Microbiology Reviews, 25(3), 285–308. https://doi.org/10.1111/j.1574-6976.2001.tb00579.x
Gonzalez, J. M., Aranda, B. (2023). Microbial growth under limiting conditions—future perspectives. Microorganisms, 11, 1641. https://doi.org/10.3390/microorganisms11071641
Hibbing, M. E., Fuqua, C., Parsek, M. R., Peterson, S. B. (2010). Bacterial competition: Surviving and thriving in the microbial jungle. Nature Reviews Microbiology, 8, 15–25. https://doi.org/10.1038/nrmicro2259
Ghoul, M., Mitri, S. (2016). The ecology and evolution of microbial competition. Trends in Microbiology, 24, 833–845. https://doi.org/10.1016/j.tim.2016.06.011
Ennahar, S., Sashihara, T., Sonomoto, K., Ishizaki, A. (2000). Class IIa bacteriocins: Biosynthesis, structure and activity. FEMS Microbiology Reviews, 24, 85–106. https://doi.org/10.1111/j.1574-6976.2000.tb00534.x
Krismer, B., Weidenmaier, C., Zipperer, A., Peschel, A. (2017). The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nature Reviews Microbiology, 15, 675–687. https://doi.org/10.1038/nrmicro.2017.104
Heilbronner, S., Krismer, B., Brötz-Oesterhelt, H., Peschel, A. (2021). The microbiome-shaping roles of bacteriocins. Nature Reviews Microbiology, 19, 726–739. https://doi.org/10.1038/s41579-021-00569-w
Gálvez, A., Abriouel, H., López, R. L., Omar, N. B. (2007). Bacteriocin-based strategies for food biopreservation. International Journal of Food Microbiology, 120(1–2), 51–70. https://doi.org/10.1016/j.ijfoodmicro.2007.06.001
Fox, J. L. (2006). The business of developing antibacterials. Nature Biotechnology, 24(12), 1521–1528. https://doi.org/10.1038/nbt1206-1521
Cotter, P. D., Ross, R. P., Hill, C. (2012). Bacteriocins—A viable alternative to antibiotics? Nature Reviews Microbiology, 11(2), 95–105. https://doi.org/10.1038/nrmicro2937
Jack, R. W., Tagg, J. R., Ray, B. (1995). Bacteriocins of Gram-positive bacteria. Microbiological Reviews, 59(2), 171–200. https://doi.org/10.1128/mr.59.2.171-200.1995
Peschel, A., Götz, F. (1996). Analysis of the Staphylococcus epidermidis genes epiF, epiE, and epiG involved in epidermin immunity. Journal of Bacteriology, 178(2), 531–536. https://doi.org/10.1128/jb.178.2.531-536.1996
Havarstein, L. S., Diep, D. B., Nes, I. F. (1995). A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Molecular Microbiology, 16(2), 229–240. https://doi.org/10.1111/j.1365-2958.1995.tb02295.x
Kokai-Kun, J. F., Walsh, S. M., Chanturiya, T., Mond, J. J. (2003). Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrobial Agents and Chemotherapy, 47(5), 1589–1597. https://doi.org/10.1128/aac.47.5.1589-1597.2003
Bastos, M. D., Coutinho, B. G., Coelho, M. L. (2010). Lysostaphin: A staphylococcal bacteriolysin with potential clinical applications. Pharmaceuticals, 3(4), 1139–1161. https://doi.org/10.3390/ph3041139
Field, D., Gaudin, N., Lyons, F., O’Connor, P. M., Cotter, P. D., Hill, C., et al. (2015). A bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius. PLOS ONE, 10(3), e0119684. https://doi.org/10.1371/journal.pone.0119684
Mak, P. (2018). Staphylococcal bacteriocins. In: Pet-to-Man Travelling Staphylococci: A World in Progress (pp. 161–171). Amsterdam, The Netherlands: Elsevier. ISBN: 9780128135488
Negash, A. W., Tsehai, B. A. (2020). Current applications of bacteriocin. International Journal of Microbiology, 2020, 4374891. https://doi.org/10.1155/2020/4374891
Namvar, A. E., Bastarahang, S., Abbasi, N., Ghehi, G. S., Farhadbakhtiarian, S., Arezi, P., Hosseini, M., Baravati, S. Z., Jokar, Z., Chermahin, S. G. (2014). Clinical characteristics of Staphylococcus epidermidis: a systematic review. GMS hygiene and infection control, 9(3), Doc23. https://doi.org/10.3205/dgkh000243
Ara, K., Hama, M., Akiba, S., Koike, K., Okisaka, K., Hagura, T., et al. (2006). Foot odor due to microbial metabolism and its control. Canadian Journal of Microbiology, 52(4), 357–364. https://doi.org/10.1139/w05-130
Huang, S. L., Chen, W. C., Shei, M. C., Liao, I. C., Chen, S. N. (1999). Studies on epizootiology and pathogenicity of Staphylococcus epidermidis in tilapia (Oreochromis) cultured in Taiwan. Zoological Studies, 38(2), 178–188.
Kubilay, A., Uluköy, G. (2004). First isolation of Staphylococcus epidermidis from cultured gilthead sea bream (Sparus aurata) in Turkey. Bulletin of the European Association of Fish Pathologists, 24(3), 137.
Ali, H. H. (2014). Isolation and identification of Staphylococcus bacteria from freshwater fish and its antibiotic sensitivity in Mosul City. Basrah Journal of Veterinary Research, 1(1), 1–10.
O'Sullivan, J. N., Rea, M. C., O'Connor, P. M., Hill, C., Ross, R. P. (2019). Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens. FEMS Microbiology Ecology, 95(1), fiy241. https://doi.org/10.1093/femsec/fiy241
Nakatsuji, T., Chen, T. H., Butcher, A. M., Trzoss, L. L., Nam, S. J., Shirakawa, K. T., ..., Gallo, R. L. (2018). A commensal strain of Staphylococcus epidermidisprotects against skin neoplasia. Science advances, 4(2), eaao4502. https://doi.org/10.1126/sciadv.aao4502
Nakatsuji, T., Chen, T. H., Narala, S., Chun, K. A., Two, A. M., Yun, T., …, Gallo, R. L. (2017). Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureusand are deficient in atopic dermatitis. Science translational medicine, 9(378), eaah4680. https://doi.org/10.1126/scitranslmed.aah4680
Allgaier, H., Jung, G., Werner, R. G., Schneider, U., Zähner, H. (1986). Epidermin: Sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. European Journal of Biochemistry, 160, 9–22. https://doi.org/10.1111/j.1432-1033.1986.tb09933.x
Schnell, N., Entian, K. D., Schneider, U., Götz, F., Zähner, H., Kellner, R., Jung, G. (1988). Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature, 333(6170), 276–278. https://doi.org/10.1038/333276a0
Bierbaum, G., Götz, F., Peschel, A., Kupke, T., van de Kamp, M., Sahl, H. G. (1996). The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie van Leeuwenhoek, 69, 119–127. https://doi.org/10.1007/BF00399417
Weil, H. P., Beck-Sickinger, A. G., Metzger, J., Stevanovic, S., Jung, G., Josten, M., Sahl, H. G. (1990). Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. European journal of biochemistry, 194(1), 217–223. https://doi.org/10.1111/j.1432-1033.1990.tb19446.x
Ekkelenkamp, M. B., Hanssen, M., Danny Hsu, S. T., de Jong, A., Milatovic, D., Verhoef, J., & van Nuland, N. A. (2005). Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis. FEBS letters, 579(9), 1917–1922. https://doi.org/10.1016/j.febslet.2005.01.083
Velásquez, J. E., Zhang, X., van der Donk, W. A. (2011). Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate. Chemistry & Biology, 18, 857–867. https://doi.org/10.1016/j.chembiol.2011.05.007
Janek, D., Zipperer, A., Kulik, A., Krismer, B., Peschel, A. (2016). High frequency and diversity of antimicrobial activities produced by nasal Staphylococcus strains against bacterial competitors. PLoS Pathogens, 12, e1005812. https://doi.org/10.1371/journal.ppat.1005812
Wertheim, H. F. L., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., Nouwen, J. L. (2005). The role of nasal carriage in Staphylococcus aureus The Lancet Infectious Diseases, 5, 751–762.
Otto, M. (2014). Staphylococcus aureus Current Opinion in Microbiology, 17, 32–37.
Powers, M. E., Wardenburg, J. B. (2014). Igniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis. PLoS Pathogens, 10, e1003871.
Bastos, M., Ceotto, H., Coelho, M., Nascimento, J. (2009). Staphylococcal antimicrobial peptides: Relevant properties and potential biotechnological applications. Current Pharmaceutical Biotechnology, 10, 38–61.
Saising, J., Dube, L., Ziebandt, A. K., Voravuthikunchai, S. P., Nega, M., Götz, F. (2012). Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis Antimicrobial Agents and Chemotherapy, 56, 5804–5810.
Bierbaum, G., Sahl, H. G. (2009). Lantibiotics: Mode of action, biosynthesis and bioengineering. Current Pharmaceutical Biotechnology, 10, 2–18.
Harder, J., Bartels, J., Christophers, E., Schröder, J. M. (1997). A peptide antibiotic from human skin. Nature, 387(6636), 861. https://doi.org/10.1038/43088
Aires de Sousa, M., Sanches, I. S., Ferro, M. L., Vaz, M. J., Saraiva, Z., Tendeiro, T., ..., de Lencastre, H. (1998). Intercontinental spread of a multidrug-resistant methicillin-resistant Staphylococcus aureus clone. Journal of clinical microbiology, 36(9), 2590–2596. https://doi.org/10.1128/JCM.36.9.2590-2596.1998
Bannerman, T. L. (2003). Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically. In: Murray, P. R., Baron, E. J., Jorgensen, J. H., Pfaller, M. A., Yolken, R. H. (Eds.), Manual of Clinical Microbiology (8th ed., Vol. 1, pp. 384–404). Washington, DC: American Society for Microbiology.
Lowy, F. D. (1998). Staphylococcus aureus The New England Journal of Medicine, 339(8), 520–532. https://doi.org/10.1056/NEJM199808203390806
Ellington, J. K., Harris, M., Webb, L., Smith, B., Smith, T., Tan, K., Hudson, M. (2003). Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis. The Journal of bone and joint surgery. British volume, 85(6), 918–921.
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., Fowler, V. G. (2015). Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews, 28(3), 603–661. https://doi.org/10.1128/cmr.00134-14
Fowler, V. G., Jr, Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., …, ICE Investigators (2005). Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA, 293(24), 3012–3021. https://doi.org/10.1001/jama.293.24.3012
Saeed, K., Bal, A. M., Gould, I. M., David, M. Z., Dryden, M., Giannitsioti, E., ..., Voss, A. (2019). An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC). International journal of antimicrobial agents, 53(1), 9–15. https://doi.org/10.1016/j.ijantimicag.2018.09.014
Pletz, M. W., Burkhardt, O., Welte, T. (2010). Nosocomial methicillin-resistant Staphylococcus aureus pneumonia: Linezolid or vancomycin? Comparison of pharmacology and clinical efficacy. Infection, 15, 507–513. https://doi.org/10.1186/2047-783x-15-12-507
Lesher, B., Gao, X., Chen, Y., Liu, Z. (2016). Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: Role of linezolid in the People’s Republic of China. Clinical Outcomes Research, 8, 63–72. https://doi.org/10.2147/CEOR.S91985
Laux, C., Peschel, A., Krismer, B. (2019). Staphylococcus aureus colonization of the human nose and interaction with other microbiome members. Microbiology Spectrum, 7(2). https://doi.org/10.1128/microbiolspec.gpp3-0029-2018
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., ..., V. G., Jr (2019). Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nature reviews. Microbiology, 17(4), 203–218. https://doi.org/10.1038/s41579-018-0147-4
Kobayashi, T., Nagao, K. (2019). Host–microbial dialogues in atopic dermatitis. International Immunology, 31(7), 449–456. https://doi.org/10.1093/intimm/dxz026
Blicharz, L., Rudnicka, L., Samochocki, Z. (2019). Staphylococcus aureus: An underestimated factor in the pathogenesis of atopic dermatitis? Advances in Dermatology and Allergology, 36(1), 11–17. https://doi.org/10.5114/ada.2019.82821
Kong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., ..., Segre, J. A. (2012). Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome research, 22(5), 850–859. https://doi.org/10.1101/gr.131029.111
Brauweiler, A. M., Goleva, E., Leung, N. Y. (2019). Staphylococcus aureus lipoteichoic acid damages the skin barrier through an IL-1–mediated pathway. Journal of Investigative Dermatology, 139(8), 1753–1761. https://doi.org/10.1016/j.jid.2019.02.006
Nakamura, Y., Oscherwitz, J., Cease, K. B., Chan, S. M., Muñoz-Planillo, R., Hasegawa, ..., Núñez, G. (2013). Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature, 503(7476), 397–401. https://doi.org/10.1038/nature12655
Williams, M. R., Gallo, R. L. (2015). The role of the skin microbiome in atopic dermatitis. Current Allergy and Asthma Reports, 15(6), 65. https://doi.org/10.1007/s11882-015-0567-4
Hepburn, L., Hijnen, D., Sellman, B., Mustelin, T., Sleeman, M., May, R., Strickland, I. (2017). The complex biology and contribution of Staphylococcus aureus in atopic dermatitis: Current and future therapies. British Journal of Dermatology, 177(1), 63–71. https://doi.org/10.1111/bjd.15139
Cogen, A. L., Yamasaki, K., Sanchez, K. M., Dorschner, R. A., Lai, Y., MacLeod, D. T., ..., Gallo, R. L. (2010). Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. Journal of Investigative Dermatology, 130(1), 192–200. https://doi.org/10.1038/jid.2009.243
Cogen, A. L., Yamasaki, K., Muto, J., Sanchez, K. M., Crotty Alexander, L., Tanios, J., ..., Gallo, R. L. (2010). Staphylococcus epidermidis antimicrobial δ-toxin (phenol-soluble modulin-γ) cooperates with host antimicrobial peptides to kill group A Streptococcus. PLoS ONE, 5(1), e8557. https://doi.org/10.1371/journal.pone.0008557
Nguyen, T. H., Park, M. D., Otto, M. (2017). Host response to Staphylococcus epidermidis colonization and infections. Frontiers in Cellular and Infection Microbiology, 7, 90. https://doi.org/10.3389/fcimb.2017.00090
Lai, Y., Di Nardo, A., Nakatsuji, T., Leichtle, A., Yang, Y., Cogen, A. L., ..., Gallo, R. L. (2009). Commensal bacteria regulate Toll-like receptor 3–dependent inflammation after skin injury. Nature Medicine, 15(12), 1377–1382.
Lai, Y., Cogen, A. L., Radek, K. A., Park, H. J., Macleod, D. T., Leichtle, A., ..., Gallo, R. L. (2010). Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. Journal of Investigative Dermatology, 130(8), 2211–2221. https://doi.org/10.1038/jid.2010.123
Wanke, I., Steffen, H., Christ, C., Krismer, B., Götz, F., Peschel, A., ..., Schittek, B. (2011). Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. Journal of Investigative Dermatology, 131(2), 382–390. https://doi.org/10.1038/jid.2010.349
Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M. J., Salcedo, R., Kastenmuller, W., ..., Belkaid, Y. (2012). Compartmentalized control of skin immunity by resident commensals. Science, 337(6102), 1115–1119.
Li, D., Lei, H., Li, Z., Li, H., Wang, Y., Lai, Y. (2013). A novel lipopeptide from skin commensal activates TLR2/CD36-p38 MAPK signaling to increase antibacterial defense against bacterial infection. PLOS ONE, 8(10), e58288. https://doi.org/10.1371/journal.pone.0058288
Naik, S., Bouladoux, N., Linehan, J. L., Han, S. J., Harrison, O. J., Wilhelm, C., ..., Belkaid, Y. (2015). Commensal–dendritic-cell interaction specifies a unique protective skin immune signature. Nature, 520(7548), 104–108.
Laborel-Préneron, E., Bianchi, P., Boralevi, F., Lehours, P., Fraysse, F., Morice-Picard, F., ..., Davrinche, C. (2015). Effects of the Staphylococcus aureus and Staphylococcus epidermidis secretomes isolated from the skin microbiota of atopic children on CD4+ T cell activation. PLOS ONE, 10(12), e0144323. https://doi.org/10.1371/journal.pone.0144323
Scharschmidt, T. C., Vasquez, K. S., Truong, H. A., Gearty, S. V., Pauli, M. L., Nosbaum, A., ..., Rosenblum, M. D. (2015). A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity, 43(5), 1011–1021. https://doi.org/10.1016/j.immuni.2015.10.016
Park, B., Iwase, T., Liu, G. Y. (2011). Intranasal application of Staphylococcus epidermidis prevents colonization by methicillin-resistant Staphylococcus aureus in mice. PLOS ONE, 6(10), e25880. https://doi.org/10.1371/journal.pone.0025880
Iwase, T., Uehara, Y., Shinji, H., Tajima, A., Seo, H., Takada, K., ..., Mizunoe, Y. (2010). Staphylococcus epidermidisEsp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature, 465, 346–349. https://doi.org/10.1038/nature09074
Chen, C., Krishnan, V., Macon, K., Manne, K., Narayana, S. V. L., Schneewind, O. (2013). Secreted proteases control autolysin-mediated biofilm growth of Staphylococcus aureus. Journal of Biological Chemistry, 288, 29440–29452. https://doi.org/10.1074/jbc.M113.502039
Mann, E. E., Rice, K. C., Boles, B. R., Endres, J. L., Ranjit, D., Chandramohan, L., ..., Bayles, K. W. (2009). Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLOS ONE, 4, e5822. https://doi.org/10.1371/journal.pone.0005822
Huseby, M. J., Kruse, A. C., Digre, J., Kohler, P. L., Vocke, J. A., Mann, E. E., ..., Earhart, C. A. (2010). Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proceedings of the National Academy of Sciences of the United States of America, 107, 14407–14412. https://doi.org/10.1073/pnas.0911032107
Sugimoto, S., Iwamoto, T., Takada, K., Okuda, K., Tajima, A., Iwase, T., Mizunoe, Y. (2013). Staphylococcus epidermidisEsp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host–pathogen interaction. Journal of Bacteriology, 195, 1645–1655. https://doi.org/10.1128/JB.01672-12
Rahim, K., Saleha, S., Zhu, X., Huo, L., Basit, A., Franco, O. L. (2017). Bacterial contribution in chronicity of wounds. Microbial Ecology, 73, 710–721. https://doi.org/10.1007/s00248-016-0867-9
Hussein, Y. A., Luti, K. J. K. (2020). Probiotic application of bacteriocin-producing Staphylococcus epidermidis in a cellulosic pad to treat some skin infections. Iraqi Journal of Science, 61, 1932–1943. https://doi.org/10.24996/ijs.2020.61.8.10
Al-Malkey, M. K., Ibrahim, A. H., Ismeel, M. C. H., Sameer, F. O., Beram, I. A., Jasim, I. A. H. (2020). Synergistic antibacterial activity of epidermin and Staphylolysin LasA against pathogenic bacteria. Biomedical and Pharmacology Journal, 13, 199–206. https://doi.org/10.13005/bpj/1916
Bek-Thomsen, M., Lomholt, H. B., Kilian, M. (2008). Acne is not associated with yet-uncultured bacteria. Journal of Clinical Microbiology, 46, 3355–3360. https://doi.org/10.1128/JCM.00799-08
Grice, E. A., Segre, J. A. (2011). The skin microbiome. Nature Reviews Microbiology, 9, 244–253. https://doi.org/10.1038/nrmicro2537
Di Domizio, J., Pagnoni, A., Huber, M., Hohl, D., Gilliet, M. (2016). The skin microbiota: A colossus steps into the spotlight. Revue Médicale Suisse, 12, 660–664. https://doi.org/10.53738/revmed.2016.12.512.0660
Wang, Y., Kao, M. S., Yu, J., Huang, S., Marito, S., Gallo, R. L., Nakatsuji, T. (2016). A precision microbiome approach using sucrose for selective augmentation of Staphylococcus epidermidis fermentation against Propionibacterium acnes. International Journal of Molecular Sciences, 17, 1870. https://doi.org/10.3390/ijms17111870
Fulton, J. E., Jr., Farzad-Bakshandeh, A., Bradley, S. (1974). Studies on the mechanism of action of topical benzoyl peroxide and vitamin A acid in acne vulgaris. Journal of Cutaneous Pathology, 1, 191–200. https://doi.org/10.1111/j.1600-0560.1974.tb00628.x
Michel, S., Jomard, A., Démarchez, M. (1998). Pharmacology of adapalene. British Journal of Dermatology, 139, 3–7.
Tenaud, I., Khammari, A., & Dréno, B. (2007). In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Experimental Dermatology, 16, 500–506. https://doi.org/10.1111/j.1600-0625.2007.00552.x
Ozolins, M., Eady, E. A., Avery, A. J., Cunliffe, W. J., Po, A. L. W., O’Neill, C., Whitehouse, H., Williams, H. C. (2004). Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: Randomised controlled trial. Lancet, 364, 2188–2195. https://doi.org/10.1016/S0140-6736(04)17591-0
Nishijima, S., Kurokawa, I., Katoh, N., Watanabe, K. (2000). The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. Journal of Dermatology, 27, 318–323. https://doi.org/10.1111/j.1346-8138.2000.tb02174.x
Moon, S. H., Roh, H. S., Kim, Y. H., Kim, J. E., Ko, J. Y., Ro, Y. S. (2012). Antibiotic resistance of microbial strains isolated from Korean acne patients. Journal of Dermatology, 39, 833–837. https://doi.org/10.1111/j.1346-8138.2012.01626.x
Nakase, K., Nakaminami, H., Takenaka, Y., Hayashi, N., Kawashima, M., Noguchi, N. (2014). Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan. Journal of Medical Microbiology, 63, 721–728. https://doi.org/10.1099/jmm.0.067611-0
Dréno, B., Gollnick, H. P., Kang, S., Thiboutot, D., Bettoli, V., Torres, V., Bettoli, V. (2015). Understanding innate immunity and inflammation in acne: Implications for management. Journal of the European Academy of Dermatology and Venereology, 29, 3–11.
Simonart, T., Dramaix, M., De Maertelaer, V. (2008). Efficacy of tetracyclines in the treatment of acne vulgaris: A review. British Journal of Dermatology, 158, 208–216. https://doi.org/10.1111/j.1365-2133.2007.08286.x
Wang, Y., Kuo, S., Shu, M., Yu, J., Huang, S., Dai, A., Nakatsuji, T. (2014). Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: Implications of probiotics in acne vulgaris. Applied Microbiology and Biotechnology, 98, 411–424. https://doi.org/10.1007/s00253-013-5394-8
Claudel, J. P., Auffret, N., Leccia, M. T., Poli, F., Corvec, S., Dréno, B. (2019). Staphylococcus epidermidis: A potential new player in the physiopathology of acne. Dermatology, 235, 287–294.
Skabytska, Y., Biedermann, T. (2016). Staphylococcus epidermidis sets things right again. Journal of Investigative Dermatology, 136, 559–560. https://doi.org/10.1016/j.jid.2015.11.016
Białecka, A., Mak, M., Biedroń, R., Bobek, M., Kasprowicz, A., Marcinkiewicz, J. (2005). Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: Implications for chronic inflammatory acne. Archivum Immunologiae et Therapiae Experimentalis, 53, 79–85.
Green, M. J., Green, L. E., Medley, G. F., Schukken, Y. H., Bradley, A. J. (2002). Influence of dry period bacterial intramammary infection on clinical mastitis in dairy cows. Journal of Dairy Science, 85, 2589–2599. https://doi.org/10.3168/jds.S0022-0302(02)74343-9
Gruet, P., Maincent, P., Berthelot, X., Kaltsatos, V. (2001). Bovine mastitis and intramammary drug delivery: Review and perspectives. Advanced Drug Delivery Reviews, 50, 245–259. https://doi.org/10.1016/S0169-409X(01)00160-0
Bradley, A. J. (2002). Bovine mastitis: An evolving disease. Veterinary Journal, 164, 116–128. https://doi.org/10.1053/tvjl.2002.0724
Barkema, H. W., Schukken, Y. H., Zadoks, R. N. (2006). The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus Journal of Dairy Science, 89, 1877–1895. https://doi.org/10.3168/jds.S0022-0302(06)72256-1
Talon, R., Leroy, S., Lebert, I., Giammarinaro, P., Chacornac, J. P., Latorre-Moratalla, M., Bover-Cid, S. (2008). Safety improvement and preservation of typical sensory qualities of traditional dry fermented sausages using autochthonous starter cultures. International Journal of Food Microbiology, 126, 227–234.
Seitter, M., Geng, B., Hertel, C. (2011). Binding to extracellular matrix proteins and formation of biogenic amines by food-associated coagulase-negative staphylococci. International Journal of Food Microbiology, 145, 483–487.
Yongsawatdigul, J., Rodtong, S., Raksakulthai, N. (2007). Acceleration of Thai fish sauce fermentation using proteinases and bacterial starter cultures. Journal of Food Science, 72, 382–390.
Xu, P., Yang, H., Tian, L., Guo, Q., Chen, H., Wei, X., Liu, Y. (2023). Function and safety evaluation of Staphylococcus epidermidis with high esterase activity isolated from strong flavor Daqu. LWT – Food Science and Technology, 176, 114534. https://doi.org/10.1016/j.lwt.2023.114534
Otto, M. (2009). Staphylococcus epidermidis—the “accidental” pathogen. Nature Reviews Microbiology, 7, 555–567. https://doi.org/10.1038/nrmicro2182
Hedin, G. (1993). Staphylococcus epidermidis—hospital epidemiology and the detection of methicillin resistance. Scandinavian Journal of Infectious Diseases Supplement, 90, 1–59.
Itah, A. Y., Essien, J. P. (2005). Growth profile and hydrocarbonoclastic potential of microorganisms isolated from tarballs in the Bight of Bonny, Nigeria. World Journal of Microbiology and Biotechnology, 21, 1317–1322. https://doi.org/10.1007/s11274-004-6694-z
Mei, M., Estrada, I., Diggle, S. P., & Goldberg, J. B. (2025). R-pyocins as targeted antimicrobials against Pseudomonas aeruginosa. npj Antimicrobial Resistance, 3, 17. https://doi.org/10.1038/s44259-025-00088-1
Suleman, M., Yaseen, A. R., Ahmed, S., Khan, Z., Irshad, A., Pervaiz, A., ..., Azhar, M. ( (2025). Pyocins and beyond: Exploring the world of bacteriocins in Pseudomonas aeruginosa. Probiotics and Antimicrobial Proteins, 17, 240–252. https://doi.org/10.1007/s12602-024-10322-3